LOUISVILLE, Ky. / Mar 22, 2023 / Business Wire / The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023.
Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023.
“I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation’s reach has expanded nationally,” said Mr. Jones. “As board chair and a champion for our communities, I look forward to continuing our efforts to build healthier communities and eliminate barriers to equitable health and healthcare.”
Bruce Broussard, Humana Inc.’s President and Chief Executive Officer, will step down as the Foundation’s Chairman, but will continue to serve on the Foundation’s Board.
“The Humana Foundation has a strong history of helping people achieve their best health and I am excited about David’s leadership of those efforts,” said Broussard. “I am inspired by David’s passion for the Foundation’s mission and his compassion for the people we serve.”
About The Humana Foundation
The Humana Foundation was established in 1981 as the philanthropic arm of Humana Inc. and is focused on health equity, working to eliminate unjust, avoidable and unnecessary barriers in health and healthcare. The Foundation fosters evidence-based collaborations and investments that help people in underserved communities live connected, healthy lives. As a steward of good health, the Foundation creates healthy emotional connections for people and communities and is shaping a healthier approach to nutrition to support lifelong well-being. For more information, visit humanafoundation.org.
Humana Inc. and The Humana Foundation believe everyone should have access to the tools and support needed to have a fair and just opportunity to be as healthy as possible. Our commitment to improving health outcomes for all – our members and patients, employees, the communities we serve, the healthcare system, and the environment - is the foundation of our Environment, Social, and Governance (ESG) impact platform.
Last Trade: | US$244.48 |
Daily Change: | 2.60 1.07 |
Daily Volume: | 1,865,567 |
Market Cap: | US$29.440B |
April 30, 2025 February 11, 2025 November 12, 2024 October 30, 2024 October 24, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load